Prelude Therapeutics Incorporated logo

Prelude Therapeutics Incorporated (PRLD)

Market Open
1 Sep, 19:45
NASDAQ (NGS) NASDAQ (NGS)
$
5. 52
-0.08
-1.4286%
$
318.82M Market Cap
- P/E Ratio
- Div Yield
448,641 Volume
-2 Eps
$ 5.6
Previous Close
Investors:
Add Transaction
Day Range
5.27 5.58
Year Range
0.98 6.83
Want to track PRLD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Prelude Therapeutics Incorporated Investors

Name Quantity Cost Value Profit ($) Gain (%)
John H. Burbank III
John H. Burbank III Passport Capital LLC
10.12M $305.1M $56.19M -$248.91M -81.58%
Joseph Castro
Joseph Castro Nuveen LLC
37,023 $155,496.6 $178,821.09 $23,324.49 15%
Drew Phillips
Drew Phillips Fortitude Family Office LLC
230 $787 $1,058 $271 34.43%
Hui Fai Tam
Hui Fai Tam Caitong International Asset Management Co. Ltd.
18 $75.6 $81.36 $5.76 7.62%
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
10,492 $44,066.4 $48,263.2 $4,196.8 9.52%